Tag: Pharmaceutical Industry

SID&GP reported about the dynamics of pharma industry in the Moscow region

dubna-sez
On October 2, 2018, the Dubna Special Economic Zone hosted a conference to support the development of the medical and pharmaceutical industry of the Moscow Region.

The third issue of “CIS GMP news” English-language magazine is out

autumn-2018
The autumn issue of the "CIS GMP news" English-language publication presents the development of the pharmaceutical industry in Russia and other EAEU member countries to the international community.

60% of pharma and life science organisations are using or testing blockchain

blockchain
The Pistoia Alliance announced the results of a survey on the adoption of blockchain in the pharmaceutical and life science industries.

Russian Export Center stood out as the general partner of BIOTECHMED 2018

biotechmed
Russia's key biomedical technologies forum BIOTECHMED 2018 was held in Gelendzhik on September, 9-11 with the Russian Export Center acting as the general partner of the event.

New research on the Top 25 pharma companies by market capitalization

pharma
The performance highlights of the Top 25 publicly traded global pharmaceutical companies by Market Cap for the quarter ended June 30, 2018, compared to the quarter ended March 31, 2018.

UK asked drugmakers for extra six weeks of Brexit drug stockpiles

pills
The British government called for drugmakers to build an additional six weeks of medicines stockpiles to cope with potential supply disruption in the event of a no-deal Brexit.

Tjoapack join forces with Veratrak to advance blockchain in pharma industry

blockchain
Global contract packaging organisation (CPO), Tjoapack, has partnered with UK-based technology company, Veratrak, to establish the use of blockchain across the pharmaceutical industry.

Uzbekistan prepared its concept of pharma industry development

uzpharmsanoat
The Agency for the Development of the Pharmaceutical Industry has prepared a draft Concept for the development of the pharmaceutical industry in Uzbekistan for 2018-2022.

Russia has prepared a medical industry development strategy up to 2030

med-devices
The Ministry of Industry and Trade prepared a draft decree of "On the approval of the Strategy for the Development of the Medical Industry of the Russian Federation for the Period up to 2030".

Leading pharma manufacturers to expand their stocks before Brexit

pharmacy
The European Medicines Agency has warned drugmakers they needed to be ready for a possible hard Brexit in 2019.

Indian pharma companies obtained 125 FDA approvals during H1 2018

pills
Indian Pharma companies and their subsidiaries have received 125 final ANDA approvals from US FDA during the first half ended June 2018 out of total 323 Abbreviated New Drug Applications approvals.

British Parliament voted to keep UK in EMA after Brexit

uk-eu
On July 17, The UK Parliament voted 305-301 in favor of continuing the UK’s involvement with the European Medicines Agency (EMA) after the island leaves the EU.

EMA survey displayed gaps in pharma industry preparedness for Brexit

european medicines agency
Regulatory authorities and marketing authorisation holders both play an important part in preparing for the consequences of Brexit to safeguard the continuous supply of medicines after the withdrawal of the UK from EU.

GlobalData named the top 25 pharma companies by market capitalization

pharma-market
GlobalData has tracked the market capitalization performance of the Top 25 pharma companies for the quarter ending 31 March, 2018 compared to 2017 revealing a number of interesting insights.

Deloitte’s recent survey reflects the increasing role of real-world evidence

deloitte
Deloitte’s real-world evidence (RWE) benchmarking survey studies how biopharma companies are using RWE, what they are investing in, areas of impact, and the hurdles to successful adoption.

Global biotech conference started in South Korea

korea
The 2018 Global Bio Conference kicked off in Seoul, bringing together biotech regulators and industry experts from around the world to support the growth and overseas expansion of South Korea’s biopharmaceutical businesses.